Alimera Sciences is a global pharmaceutical company dedicated to protecting the retina and preserving vision. With a focus on retinal disease, they strive to provide innovative treatments and collaborate with providers, patients, and partners to improve outcomes and change lives.
Driven by a passion for the retina and its crucial role in enabling us to see the world, Alimera Sciences recognizes the limitations of current therapies and aims to address the needs of aging populations affected by retinal diseases. They believe in the power of collaboration and the collective value of their organization, working together to develop invaluable solutions for patients, physicians, and partners concerned with retinal health and maintaining better vision for longer.
Generated from the website